MedPath

Efficacy and safety of sodium-glucose cotransporter-2 inhibitor in patients with type 2 diabetes

Not Applicable
Conditions
Type 2 diabetes mellitus
Registration Number
JPRN-UMIN000017625
Lead Sponsor
Department of Cardiology, Fukuoka University Hospital.
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
50
Inclusion Criteria

Not provided

Exclusion Criteria

1.Severe ketosis and diabetic coma 2.Type 1 diabetes mellitus 3.Severe liver dysfunction 4.Severe renal dysfunction 5.Pregnancy or lactation in women 6.Patients with a history of allergy to any component of the study medications 7.Patients corresponding to the contraindication of study medications 8.Ineligible patients according to the judgment by physician

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath